Carregant...
A Review on: Phase ‘0’ Clinical Trials or Exploratory Investigational New Drug
In a move to speed up the development of new medicines, the Food and Drug Administration announced in January 2006 the creation of the exploratory Investigational New Drug (IND), the so-called phase ‘0’ clinical trials. This guidance is intended to clarify what preclinical and clinical approaches, a...
Guardat en:
| Publicat a: | Turk J Pharm Sci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Galenos Publishing
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227998/ https://ncbi.nlm.nih.gov/pubmed/32454598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjps.63935 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|